Dapsone
- Product NDC
- 42291-298
- 11-digit product format
- 422910298
- Labeler code
- 42291
- Product ID
- 42291-298_6364164c-f2ed-d007-e053-2991aa0a0115
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dapsone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvKARE, Inc.
- Application
- ANDA204074
- Marketing category
- ANDA
- Marketing start
- 2017-05-17
- Marketing end
- 0000-00-00
- Substance
- DAPSONE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Sulfone [EPC],Sulfones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-298-90 | 42291029890 | 90 TABLET in 1 BOTTLE (42291-298-90) | 90 tablet | 2017-05-17 | 0000-00-00 | No | No | Current |